Anticorps Monoclonal anti-SPARC
SPARC Monoclonal Antibody for IF/ICC
Hôte / Isotype
Mouse / IgG2a
Réactivité testée
Humain, rat
Applications
IF/ICC
Conjugaison
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
1A2C1
N° de cat : CL488-66426
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en IF/ICC | cellules C6, |
Dilution recommandée
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
CL488-66426 cible SPARC dans les applications de IF/ICC et montre une réactivité avec des échantillons Humain, rat
Réactivité | Humain, rat |
Hôte / Isotype | Mouse / IgG2a |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | SPARC Protéine recombinante Ag7390 |
Nom complet | secreted protein, acidic, cysteine-rich (osteonectin) |
Masse moléculaire calculée | 35 kDa |
Poids moléculaire observé | 38 kDa, 52 kDa |
Numéro d’acquisition GenBank | BC004974 |
Symbole du gène | SPARC |
Identification du gène (NCBI) | 6678 |
Conjugaison | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 493 nm / 522 nm |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA |
Conditions de stockage | Stocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
SPARC, also known as ON (Osteonectin) or BM-40 (Basement-membrane protein 40), is an extracellular glycoprotein with the calculated molecular mass of 35 kDa and the apparent molecular mass of 40-43 kDa and 50 kDa (PMID: 7495300, 12365801). SPARC belongs to a group of matricellular proteins defined as secreted components that do not contribute directly to the formation of structural elements but serve to modulate cell-matrix interactions and cellular functions (PMID: 7542656; 12231357). SPARC is expressed at high levels in bone tissue, is distributed widely in many other tissues and cell types, and is associated generally with tissues undergoing morphogenesis, remodeling and wound repair (PMID: 10567433). It elicits changes in cell shape, inhibits cell-cycle progression, and influences the synthesis of extracellular matrix (PMID: 12721366). Altered expression of SPARC has been reported in a variety of cancers, which include breast, ovarian, colorectal, and pancreatic cancer as well as melanoma and glioblastomas (PMID: 18849185).
Protocole
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 SPARC antibody CL488-66426 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |